All individual trials at AC Camargo Cancer Center

An AllTrials project

All individual trials at AC Camargo Cancer Center

0 out of 2

0.0%

$6,108,432

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	AC Camargo Cancer Center	NCT03870399	Phase II Study of Hormone Therapy With Tamoxifen in Patients With Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression	2023-05-13	470
overdue	AC Camargo Cancer Center	NCT04993014	Circulating Tumor Cells and Adjuvant Treatment De-escalation After Neoadjuvant Therapy With Trastuzumab and Pertuzumab for HER2 Positive Early Breast Cancer	2024-04-30	118
ongoing	AC Camargo Cancer Center	NCT06472388	Randomized Phase II Trial of Everolimus 5 mg vs 10 mg/Daily for Patients With Advanced Neuroendocrine Tumors	2026-05-20

Download this data